These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2772285)

  • 21. Efficacy of incorporating cyclosporine into liposomes to reduce its nephrotoxicity.
    Smeesters C; Giroux L; Vinet B; Arnoux R; Chaland P; Corman J; St-Louis G; Daloze P
    Can J Surg; 1988 Jan; 31(1):34-6. PubMed ID: 3257403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute cyclosporine-induced renal vasoconstriction: lack of effect of theophylline.
    Churchill PC; Rossi NF; Churchill MC; Bidani AK; McDonald FD
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F41-5. PubMed ID: 2301595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deleterious effect of cyclosporins on the ischemic kidney in the rat and the protection by the calcium antagonist verapamil.
    Ar'Rajab A; Dawidson IJ; Harris RB; Mileski WJ; Sentementes JT
    J Am Soc Nephrol; 1994 Jul; 5(1):93-101. PubMed ID: 7948788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of tacrolimus and cyclosporine on renal microcirculation and nitric oxide production.
    Watarai Y; Morita K; Shimoda N; Miura M; Yoshioka M; Togashi H; Nonomura K; Koyanagi T
    Transplant Proc; 2004 Sep; 36(7):2130-2. PubMed ID: 15518773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute cyclosporine A-induced nephrotoxicity: a rabbit model.
    Prévot A; Semama DS; Justrabo E; Guignard JP; Escousse A; Gouyon JB
    Pediatr Nephrol; 2000 May; 14(5):370-5. PubMed ID: 10805463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The renal hemodynamic response to endothelin in chronic cyclosporine-treated dogs.
    Fisch J; Gulmi FA; Chou SY; Mooppan UM; Kester RR; Kim H
    J Urol; 1993 Apr; 149(4):878-83. PubMed ID: 8455268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of endothelin in cyclosporine-induced glomerular dysfunction.
    Kon V; Sugiura M; Inagami T; Harvie BR; Ichikawa I; Hoover RL
    Kidney Int; 1990 Jun; 37(6):1487-91. PubMed ID: 2194067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity.
    Coffman TM; Carr DR; Yarger WE; Klotman PE
    Transplantation; 1987 Feb; 43(2):282-5. PubMed ID: 3810836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
    Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C
    Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effects of cyclosporine on glomerular function.
    Wiegmann TB; Sharma R; Diederich DA; Savin VJ
    Am J Med Sci; 1990 Mar; 299(3):149-52. PubMed ID: 2316558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of prostacyclin on postischemic acute renal failure in the rat.
    Finn WF; Hak LJ; Grossman SH
    Kidney Int; 1987 Oct; 32(4):479-87. PubMed ID: 3323594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic characterization of a pig model of ciclosporin A nephrotoxicity following intravenous administration.
    Cibulskyte D; Pedersen M; Jakobsen P; Hansen HE; Mortensen J
    Pharmacol Res; 2007 Oct; 56(4):311-7. PubMed ID: 17870611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal blood flow, glomerular filtration rate, and renal morphology in cyclosporine-induced acute renal failure in Munich-Wistar rats.
    Racusen LC; Kone BC; Whelton A; Solez K
    Am J Kidney Dis; 1986 Nov; 8(5):319-22. PubMed ID: 3788971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic vascular effects of cyclosporin A treatment in normotensive rats.
    Rego A; Vargas R; Cathapermal S; Kuwahara M; Foegh ML; Ramwell PW
    J Pharmacol Exp Ther; 1991 Nov; 259(2):905-15. PubMed ID: 1941635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synergistic effects of cyclosporine and endothelin--demonstration of an important cardiodepressor action.
    Edwards BS; Lloyd MA; Anderson LM
    Transplantation; 1993 Jan; 55(1):8-11. PubMed ID: 8420069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cumulative damaging effect of liver hypoperfusion and cyclosporine a on the peribiliary capillary plexus: a study in an isolated dually perfused rat model.
    Nakache R; Rudick V; Fiodorov D; Klausner JM; Almogy N; Karckevski E; Weinbroum AA
    Transplantation; 1999 Dec; 68(11):1651-60. PubMed ID: 10609941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
    Pollock DM; Opgenorth TJ
    Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversibility of acute cyclosporin nephrotoxicity by dopamine. Micropuncture study in the rat.
    Sabbatini M; Esposito C; De Nicola L; Uccello F; Altomonte M; Conte G; Dal Canton A; Andreucci VE
    Nephrol Dial Transplant; 1989; 4(5):327-33. PubMed ID: 2505181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of cyclosporine A-induced renal vasoconstriction in the rat.
    Rossi NF; Churchill PC; McDonald FD; Ellis VR
    J Pharmacol Exp Ther; 1989 Sep; 250(3):896-901. PubMed ID: 2778718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects.
    Conte G; Dal Canton A; Sabbatini M; Napodano P; De Nicola L; Gigliotti G; Fuiano G; Testa A; Esposito C; Russo D
    Kidney Int; 1989 Dec; 36(6):1086-92. PubMed ID: 2601257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.